Race between retroviral spread and CD4+ T-cell response determines the outcome of acute friend virus infection

Journal of Virology

Volumn 83, Issue 21, 2009, Pages 11211-11222

  Pike, Rebecca ^a   Filby, Andrew ^a   Ploquin, Mickaël J Y ^a   Eksmond, Urszula ^a   Marques, Rute ^a   Antunes, Inês ^a   Hasenkrug, Kim ^b   Kassiotis, George ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROTECTION; CONTROLLED STUDY; FRIEND LEUKEMIA VIRUS; GENETIC SUSCEPTIBILITY; IMMUNIZATION; LACTATE DEHYDROGENASE ELEVATING VIRUS; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FRIEND MURINE LEUKEMIA VIRUS; LACTATE DEHYDROGENASE-ELEVATING VIRUS; LEUKEMIA, EXPERIMENTAL; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERFERON; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

FRIEND MURINE LEUKEMIA VIRUS; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MURINAE;

EID: 70350316079     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01225-09     Document Type: Article

References (62)

1. Antunes, I., M. Tolaini, A. Kissenpfennig, M. Iwashiro, K. Kuribayashi, B. Malissen, K. Hasenkrug, and G. Kassiotis. 2008. Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity 29:782-794.
2. Balkow, S., F. Krux, K. Loser, J. U. Becker, S. Grabbe, and U. Dittmer. 2007. Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells. Blood 110:3949-3958. (Pubitemid 350248450)
3. Bock, M., K. N. Bishop, G. Towers, and J. P. Stoye. 2000. Use of a transient assay for studying the genetic determinants of Fv1 restriction. J. Virol. 74:7422-7430. (Pubitemid 30613087)
4. Brien, J. D., J. L. Uhrlaub, and J. Nikolich-Zugich. 2008. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol. 181:8568-8575.
5. Brooks, D. G., L. Teyton, M. B. A. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79:10514-10527.
6. Brown, D. M., A. M. Dilzer, D. L. Meents, and S. L. Swain. 2006. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol. 177:2888-2898.
7. + effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 81:12535-12542.
8. Carneiro-Sampaio, M., and A. Coutinho. 2007. Immunity to microbes: lessons from primary immunodeficiencies. Infect. Immun. 75:1545-1555.
9. + T lymphocytes with cellular maturation. J. Exp. Med. 203:2865-2877.
10. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishio, and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
11. Chesebro, B., K. Wehrly, and D. Housman. 1978. Lack of erythroid characteristics in Ia-positive leukemia cell lines induced by Friend murine leukemia virus: brief communication. J. Natl. Cancer Inst. 60:239-242.
12. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051-1066. (Pubitemid 121001736)
13. Dittmer, U., D. M. Brooks, and K. J. Hasenkrug. 1999. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection. Nat. Med. 5:189-193.
14. + T cells. Nature 417:95-98.
15. - lymphocytes. J. Exp. Med. 154:952-963.
16. - T cells. Tumor eradication does not require participation of cytotoxic T cells. J. Exp. Med. 161:1122-1134.
17. Grossman, Z., M. Meier-Schellersheim, W. E. Paul, and L. J. Picker. 2006. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12:289-295.
18. Haase, A. T. 1999. Population biology of HIV-1 infection: viral and CD4+ T-cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17:625-656.
19. Hasenkrug, K. J. 1999. Lymphocyte deficiencies increase susceptibility to Friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. J. Virol. 73:6468-6473.
20. + T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72:6559-6564.
21. Hasenkrug, K. J., and B. Chesebro. 1997. Immunity to retroviral infection: the Friend virus model. Proc. Natl. Acad. Sci. USA 94:7811-7816.
22. + T-cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J. Immunol. 177:8851-8859.
23. + cytotoxic T cells in CD4-deficient mice. Eur. J. Immunol. 25:1109-1112.
24. Hel, Z., J. R. McGhee, and J. Mestecky. 2006. HIV infection: first battle decides the war. Trends Immunol. 27:274-281. (Pubitemid 44183640)
25. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745. (Pubitemid 23114659)
26. Isaak, D. D., J. A. Price, C. L. Reinisch, and J. Cerny. 1979. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes. J. Immunol. 123:1822-1828.
27. Iwanami, N., A. Niwa, Y. Yasutomi, N. Tabata, and M. Miyazawa. 2001. Role of natural killer cells in resistance against Friend retrovirus-induced leukemia. J. Virol. 75:3152-3163. (Pubitemid 32225879)
28. + T cells and gamma interferon in the long-term control of persistent Friend retrovirus infection. J. Virol. 75:52-60.
29. + T cells and viremia: who's in control? Trends Immunol. 27:119-124.
30. Jellison, E. R., S. K. Kim, and R. M. Welsh. 2005. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol. 174:614-618.
31. + T-cell involvement in clearance of infectious Herpes Simplex Virus type 1 from sensory ganglia and spinal cords. J. Virol. 82:9678-9688.
32. Kabat, D. 1989. Molecular biology of Friend viral erythroleukemia. Curr. Top. Micriobiol. Immunol. 148:1-42.
33. + T cell-deficient mice against Friend retrovirus-induced disease. Int. Immunol. 18:183-198.
34. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6:873-879.
35. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448-1451. (Pubitemid 23334266)
36. Marques, R., I. Antunes, U. Eksmond, J. Stoye, K. Hasenkrug, and G. Kassiotis. 2008. B lymphocyte activation by coinfection prevents immune control of Friend virus infection. J. Immunol. 181:3432-3440.
37. Matechak, E. O., N. Killeen, S. M. Hedrick, and B. J. Fowlkes. 1996. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4:337-347.
38. Miyazawa, M., R. Fujisawa, C. Ishihara, Y. A. Takei, T. Shimizu, H. Uenishi, H. Yamagishi, and K. Kuribayashi. 1995. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. J. Immunol. 155:748-758.
39. Miyazawa, M., S. Tsuji-Kawahara, and Y. Kanari. 2008. Host genetic factors that control immune responses to retrovirus infections. Vaccine 26:2981-2996.
40. + T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ. Proc. Natl. Acad. Sci. USA 96:8633-8638.
41. Ney, P. A., and A. D. D'Andrea. 2000. Friend erythroleukemia revisited. Blood 96:3675-3680.
42. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C. J. M. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class ii negative tumors. J. Exp. Med. 187:693-702.
43. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:390-400.
44. + T Cells upon acute versus persistent viral infection. Immunity 9:449-457.
45. + Th1 cells kill Burkitt's lymphoma cells. J. Immunol. 169:1593-1603.
46. Perez-Diez, A., N. T. Joncker, K. Choi, W. F. N. Chan, C. C. Anderson, O. Lantz, and P. Matzinger. 2007. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109:5346-5354. (Pubitemid 46890556)
47. Picker, L. J. 2006. Immunopathogenesis of acute AIDS virus infection. Curr. Opin. Immunol. 18:399-405.
48. Picker, L. J., and V. C. Maino. 2000. The CD4+ T-cell response to HIV-1. Curr. Opin. Immunol. 12:381-386.
49. Qin, Z., and T. Blankenstein. 2000. CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN-γ receptor expression by nonhematopoietic cells. Immunity 12:677-686.
50. Rahemtulla, A., T. M. Kundig, A. Narendran, M. F. Bachmann, M. Julius, C. J. Paige, P. S. Ohashi, R. M. Zinkernagel, and T. W. Mak. 1994. Class II major histocompatibility complex-restricted T-cell function in CD4-deficient mice. Eur. J. Immunol. 24:2213-2218.
51. Recher, M., K. S. Lang, L. Hunziker, S. Freigang, B. Eschli, N. L. Harris, A. Navarini, B. M. Senn, K. Fink, M. Lotscher, L. Hangartner, R. Zellweger, M. Hersberger, A. Theocharides, H. Hengartner, and R. M. Zinkernagel. 2004. Deliberate removal of T-cell help improves virus-neutralizing antibody production. Nat. Immunol. 5:934-942.
52. Robertson, M. N., G. J. Spangrude, K. Hasenkrug, L. Perry, J. Nishio, K. Wehrly, and B. Chesebro. 1992. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J. Virol. 66:3271-3277.
53. + T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J. Virol. 82:408-418.
54. + T-cell responses associated with control of viremia. Science 278:1447-1450.
55. Santiago, M. L., M. Montano, R. Benitez, R. J. Messer, W. Yonemoto, B. Chesebro, K. J. Hasenkrug, and W. C. Greene. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-1346.
56. + T-cell-mediated protection from lethal Coronavirus encephalomyelitis. J. Virol. 82:12432-12440.
57. + T-cell responses in the regression of retrovirus-induced sarcomas. J. Immunol. 169:3191-3199.
58. Sparks-Thissen, R. L., D. C. Braaten, S. Kreher, S. H. Speck, and H. W. Virgin IV. 2004. An optimized CD4 T-cell response can control productive and latent Gammaherpesvirus infection. J. Virol. 78:6827-6835.
59. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727-1737.
60. Staprans, S. I., A. P. Barry, G. Silvestri, J. T. Safrit, N. Kozyr, B. Sumpter, H. Nguyen, H. McClure, D. Montefiori, J. I. Cohen, and M. B. Feinberg. 2004. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T-cell response to the SIV envelope protein. Proc. Natl. Acad. Sci. USA 101:13026-13031.
61. Stoye, J. P. 1998. Fv1, the mouse retrovirus resistance gene. Rev. Sci. Technol. 17:269-277.
62. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148-151.